CCN2 and head and neck cancer: In Chang et al.42 study, they demonstrated that CTGF expression could activate pluripotency genes NANOG, SOX2 and POU5F1 in head and neck cancer cells, and promote mesenchymal-epithelial transition, the reverse process of EMT.